奥比沙星（CAS 113617-63-3）：分子式 C19H20F3N3O3、分子量 395.4。
| CAS号 | 113617-63-3 |
|---|---|
| 分子式 | C19H20F3N3O3 |
| 分子量 | 395.4 |
| LogP | 0.9 |
| 应用领域 | Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients |
登记用途：Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients。
奥比沙星 是一种化工化合物，登记 CAS 号为 113617-63-3，分子式 C19H20F3N3O3（分子量 395.4）。
登记 CAS 号：113617-63-3
其分子式 C19H20F3N3O3 由 19 个碳、20 个氢、3 个氟、3 个氮、3 个氧 组成。
别名/同义词：奥比沙星 · Orbifloxacin
奥比沙星 的 CAS 登记号为 113617-63-3。
分子式 C19H20F3N3O3，分子量 395.4。
别名/同义词：奥比沙星、Orbifloxacin。
登记用途：Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients。
奥比沙星（CAS 113617-63-3）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 113617-63-3 |
|---|---|
| PubChem CID | 60605 |
| Molecular formula | C19H20F3N3O3 |
| IUPAC name | 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid |
| UNII (FDA) | 660932TPY6 |
| Molecular Weight | 395.4 |
|---|---|
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 395.14567599 |
| Monoisotopic Mass | 395.14567599 |
| Topological Polar Surface Area | 72.9 |
| Heavy Atom Count | 28 |
ORBIFLOXACIN; 113617-63-3; Orbax; orbifloxacine; orbifloxacino; NSC-758614; DTXSID7046201; 660932TPY6; orbifloxacinum; Orbax Tablets; RefChem:57814; DTXCID901777786; 1-cyclopropyl-7-((3S,5R)-3,5-dimethylpiperazin-4-ium-1-yl)-5,6,8-trifluoro-4-oxoquinoline-3-carboxylate; 638-855-2; MFCD00864858; 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid
| Reported hazard statements | H361 (100%) |
|---|
H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
Orbifloxacin · CAS 113617-63-3 · C19H20F3N3O3. UNII 660932TPY6.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: Orbifloxacin